Nitroarachidonic acid (NO(2)AA) inhibits protein disulfide isomerase (PDI) through reversible covalent adduct formation with critical cysteines

Author(s)

Gonzalez-Perilli, Lucia ; Mastrogiovanni, Mauricio ; Fernandes, Denise de Castro ; Rubbo, Homero ; Laurindo, Francisco ; Trostchansky, Andres

• Document type: Journal article
• Source: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS; v. 1861, n. 5, p. 9-pg., 2017-05-01.

Abstract

Background: Nitroarachidonic acid (NO(2)AA) exhibits pleiotropic anti-inflammatory actions in a variety of cell types. We have recently shown that NO(2)AA inhibits phagocytic NADPH oxidase 2 (NOX2) by preventing the formation of the active complex. Recent work indicates the participation of protein disulfide isomerase (PDI) activity in NOX2 activation. Cysteine (Cys) residues at PDI active sites could be targets for NO(2)AA- nitroalkylation regulating PDI activity which could explain our previous observation. Methods: PDI reductase and chaperone activities were assessed using the insulin and GFP renaturation methods in the presence or absence of NO(2)AA. To determine the covalent reaction with PDI as well as the site of reaction, the PEG-switch assay and LC-MS/MS studies were performed. Results and conclusions: We determined that both activities of PDI were inhibited by NO(2)AA in a dose- and time-dependent manner and independent from release of nitric oxide. Since nitroalkenes are potent electrophiles and PDI has critical Cys residues for its activity, then formation of a covalent adduct between NO(2)AA and PDI is feasible. To this end we demonstrated the reversible covalent modification of PDI by NO(2)AA. Trypsinization of modified PDI confirmed that the Cys residues present in the active site a' of PDI were key targets accounting for nitroalkene modification. General significance: PDI may contribute to NOX2 activation. As such, inhibition of PDI by NO(2)AA might be involved in preventing NOX2 activation. Future work will be directed to determine if the covalent modifications observed play a role in the reported NO(2)AA inhibition of NOX2 activity. (C) 2017 Elsevier B.V. All rights reserved. (AU)

• FAPESP's process: 13/07937-8 - Redoxome - Redox Processes in Biomedicine
• Grantee: Ohara Augusto
• Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC